Latest news from WCM.
Find media policies and procedures, information for journalists, and more.
Latest issues of WCM Magazine, Milestones, and the WCM Fact Sheet.
Browse the WCM video and photo galleries.
Follow WCM on social media and read our posting guidelines.
Learn about the WCM Newsroom.
A newly discovered genetic mutation that is found in a subtype of prostate cancer is integral to the disease’s development and growth.
Weill Cornell Medicine researchers will receive a grant from the Department of Defense to conduct an in-...
Weill Cornell Medicine (WCM) and the New York Genome Center (NYGC) were...
Study provides a framework for understanding the biological basis for chemotherapy resistance in bladder cancer.
Weill Cornell Medicine and Columbia University Medical Center, in collaboration with NewYork-Presbyterian and NYC...
A new computational approach enables researchers to predict the odds of experimental drugs succeeding in clinical trials.
A powerful next-generation genome-sequencing test developed at Weill Cornell Medicine can detect mutations that guide precision cancer treatment with over 95 percent accuracy.
Researchers from Weill Cornell Medicine, Columbia University Medical Center, NewYork-Presbyterian and NYC Health + Hospitals/Harlem seek to extend the success of precision medicine in cancer to a broad range of diseases.
The steroid dexamethasone could potentially deter the growth of a prostate cancer subtype that was previously thought to be difficult to treat with medications.
A new collaboration involving Weill Cornell Medicine will equip researchers with more precise and reliable genomic data when investigating instances of cancer.
Back to News
Weill Cornell MedicineOffice of External Affairs
1300 York Ave.Box 314
New York, NY 10065
Phone: (646) 962-9564